Dipeptidyl Peptidase-4 Inhibitors as a Third-Line Oral Antihyperglycaemic Agent in Patients with Type 2 Diabetes Mellitus: The Impact of Ethnicity

Table 1

Demographic and clinical characteristic of participants at baseline.

Characteristics	Total
	Gender ()
Male/female	51/29
Ethnicity ()
Asians/non-Asians	41/39
Age (years)	62.0 ± 9.3
Diabetes duration (years)	12.7 ± 5.8
Weight (kg)	77.6 (68.8–93.1)
Body mass index (kg/m^2)	27.5 (25.2–31.8)
HbA1c (%)	8.3 (7.7–8.9)
HbA1c (mmol/mol)	67 (61–74)